| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.095 | 0.001 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.099 | 0.002 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |